Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. These stories and more in this week’s Forbes InnovationRx newsletter.